Literature DB >> 36100803

Formation and activity of NLRP3 inflammasome and histopathological changes in the lung of corpses with COVID-19.

Morteza Gholaminejhad1,2, Mehdi Forouzesh1, Babak Ebrahimi2, Seyed Amirhosein Mahdavi1, Seyed Davood Mirtorabi1, Amirreza Liaghat3, Seyed Jalil Monabati1, Muhammad Obaid Hamza4, Gholamreza Hassanzadeh5,6,7.   

Abstract

COVID-19 is a contagious disease that attacks many organs but the lungs are the main organs affected. The inflammasome activation results in the exacerbation of inflammatory response in infectious disease. The aim of this study is to investigate the formation and activity of the NLRP3 inflammasome complex and the histopathological changes caused by the coronavirus in the lung of deceased persons with COVID-19. In total, 10 corpses; 5 corpses with no history of any infectious diseases and COVID-19 and 5 corpses with the cause of death of COVID-19 were included in this study. Lung tissue samples were harvested during autopsy under safe conditions. Fresh tissues in each group were used to measure the genes expression and proteins level of NLRP3, ASC, Caspase-1, IL-1β, IL-6 and TNF-α and a routine hematoxylin and eosin staining was performed for histological assessment. Data are represented as the means ± SD. Statistical significance difference was accepted at a p-value less than 5%. The NLRP3, ASC, Caspase-1, IL-1β, IL-6 and TNF-α genes expression and proteins level were elevated in the lung of the COVID-19 group in comparison with the control group. Histological findings presented the increasing number of polymorphonuclear leukocytes, macrophages and also pulmonary fibrosis in the lungs of corpses with the cause of death of COVID-19. High expression of NLRP3 inflammasome components and its relation with the pathophysiology of the coronavirus-infected lung suggested that targeting the NLRP3 inflammasome could be helpful in achieving a more effective treatment in patients with COVID-19.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  COVID-19; Coronavirus; Histopathology; Inflammasome; Lung; NLRP3

Year:  2022        PMID: 36100803      PMCID: PMC9470508          DOI: 10.1007/s10735-022-10101-w

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   3.156


Introduction

It was late in December 2019 that the first cases of COVID-19 appeared in Wu et al. (2020). Up to April 2021, there have been 127 million cases of COVID-19 and more than 2.79 million deaths. The disease is very contagious and it also attacks many organs in the body (Anderson et al. 2020; Larsen et al. 2020). Lungs are the main organs that get involved and show changes in CT scan both in symptomatic and asymptomatic patients (Pan et al. 2020). Alveolar epithelial cells are the main injury site in the lungs in COVID-19 disease (Li and Ma 2020). Observation of pathological findings revealed the presence of exudative inflammation occurring in the early phase of COVID-19 pneumonia (Gallelli et al. 2020). A lung CT scan is the gold standard diagnostic tool for lung complications (Buonsenso et al. 2020). Unfortunately, we still don’t have an effective drug to cure patients with COVID-19 (Brown et al. 2021). It has been shown that the virus can enter host cells through the ACE2 receptor and cause cell involvement (Ni et al. 2020). The presence of the virus in the body leads to sepsis and the creation of a cytokine storm, eventually leading to the failure of organs such as the lungs as the main hosts of the virus (Mangalmurti and Hunter 2020). This cytokine storm has been thought to be the main reason for mortality in COVID-19 patients (Cron 2021). Inflammasomes are protein complexes that initiate and advance the inflammatory cascade. The NLRP3 (NOD-, LRR- and pyrin domain-containing protein 3) inflammasome is the most well-known type of inflammasome and consists of the NLRP3 scaffold, the ASC (the adaptor molecule apoptosis-associated speck-like protein containing a CARD) adaptor, and caspase-1 (Gholaminejhad et al. 2022). Inflammasomes recognize damage signals and a diverse range of viruses, bacteria, stress that result in activation of caspase-1, which subsequently changes pro-interleukin 1β and pro-interleukin 18 into their active form and cause pyroptosis (a form of cell death) (Schroder and Tschopp 2010; Strowig et al. 2012; Zoete et al. 2014; Guo et al. 2015; Mohammed et al. 2020; Ijaz et al. 2020). These inflammasome actions result in the exacerbation of inflammatory response in infectious disease (Rodrigues et al. 2021). There are still many questions about coronavirus that we do not have answers to. Getting to know more and more about the pathogenic process of the virus is needed to end the nightmare that it caused. Accordingly, this study was designed to investigate the formation and activity of the NLRP3 inflammasome complex and the histopathological changes caused by the coronavirus in the lung of deceased persons with COVID-19.

Materials and methods

Study design

In total, 10 corpses; 5 corpses with no history of any infectious diseases and COVID-19 (Control group, mean age 41 years, range between 34 and 50) and 5 corpses with the cause of death of COVID-19 (COVID-19 group, mean age 56 years, range between 49 and 61) that coronavirus infection was confirmed by positive Real-time PCR and/or CT scan at the Hospitals, were included in this study. These corpses were brought to the Legal Medicine Organization of Tehran Province (Kahrizak, Tehran, Iran). The tissue sampling time was less than 10 h after death. Lung tissue samples were harvested during autopsy under safe conditions. The samples were harvested from the peripheral area of the lungs. The fresh specimens were put in the liquid nitrogen storage tank and then were moved to a -80 freezer and stored until the next molecular tests. The specimens for the histopathological test were put in the formaldehyde solution 4% for histological staining. The personal information of all the corpses was preserved and the samples were determined with a special code. This study was approved (ethical code: IR.LMO.REC.1399.055) by the Research Ethics Committee of the legal Medicine Organization, Islamic Republic of Iran (Biomedical Research Ethics Committee).

Real-time polymerase chain reaction (real-time PCR)

Fresh lung tissues from corpses in each group were used to measure the gene expression of NLRP3, ASC, Caspase-1, IL-1β, IL-6 and TNF-α. Total RNA was extracted from lung tissue (n = 5 per group, 3-replica) with Trizol reagent according to the manufacturer’s instructions (RiboExTM LS, GeneAll, Korea). BioFact™ RT (South Korea) Synthesis Kit was used for reverse transcription of total extracted RNA to obtain cDNA. Real-time PCR was performed using the reaction mixture contained 5 µl SYBR Green Master Mix (BioFact, South Korea), 0.8 µl primers (Forward + Reverse), 0.8 µl cDNA and 3.4 µl RNase Free dH2O (Invitrogen) in a Real-time PCR instrument (QIAGEN Rotor-Gene, Germany). Samples were incubated at 95 °C for 10 min for initial denaturation and enzyme activation. Then the following three steps were done: denaturation, at 95 °C for 15 s; annealing, at 59–61 °C for 25 s; extension and fluorescence acquiring, at 72 °C for 30 s. The 2−ΔΔCt method was applied for the relative quantification of data and normalization of GAPDH as housekeeping. The obtained data were represented as fold change gene expression compared to the control group. Primer sequences are listed in Table 1.
Table 1

Primer sequences and product size (base pair = bp)

sequenceproduct size (bp)
NLRP3ForwardGGAGTGGATGGGTTTACTGGAG165
ReverseCGTGTGTAGCGTTTGTTGAGG
PYCARD (ASC)ForwardCGTTGAGTGGCTGCTGGATG95
ReverseGCATCTTGCTTGGGTTGGTG
Caspase-1ForwardCCAGCTATGCCCACATCCTC201
ReverseTGTGATGTCAACCTCAGCTCC
IL-1βForwardCAGAAGTACCTGAGCTCGCC153
ReverseAGATTCGTAGCTGGATGCCG
IL-6ForwardCTTCGGTCCAGTTGCCTTCT169
ReverseGATGCCGTCGAGGATGTACC
TNF-αForwardCTCTTCTGCCTGCTGCACTTTG135
ReverseATGGGCTACAGGCTTGTCACTC
GAPDHForwardGTGGTCTCCTCTGACTTCAAC97
ReverseGGAAATGAGGCTTGACAAAGTGG
Primer sequences and product size (base pair = bp)

Enzyme-linked immunosorbent assay (ELISA)

To determine the protein level of NLRP3, ASC, Caspase-1, IL-1β, IL-6 and TNF-α, the ELISA technique was performed. Briefly, the fresh lung tissue (n = 5 per group, 3-replica) was homogenized and was used for the analysis of the protein levels using human ELISA kits (NLRP3, MBS917009, MyBioSource, USA; ASC, CSB-EL019114HU, CUSABIO, USA; Caspase-1, MBS264676, MyBioSource, USA; IL-1β, 850.006.096, Diaclone, France; IL-6, 950.030.096, Diaclone, France; TNF-α, 950.090.096, Diaclone, France). According to each company’s protocol, the experiments were done.

Histological study

Lung specimens were fixed in formaldehyde solution 4%, buffered, pH 6.9 (Merck, Germany). Lung tissue samples were dehydrated and were embedded in paraffin (Merck, Germany) and sectioned into 5 μm thickness slices with 25 μm intervals. A usual hematoxylin and eosin (H&E) staining was performed for histological assessment. Five sections from each corpse were used for evaluations. Two histopathologists, blinded to the groups, evaluated the sections. The sections were visible under a light microscope (LABOMED, Labo America, Inc. USA). A digital camera (LABOMED, USA) was used to take histophotographs. Total histopathological scoring was done according to the following parameters: hemorrhage, thickened wall, inflammatory cells infiltration, and fibrotic changes with a score of None = 0, Mild = 1, Moderate = 2, and Severe = 3 (Gibson-Corley et al. 2013).

Statistical analysis

Statistical analyses were carried out by GraphPad Prism (version 8.0.0 for Windows, GraphPad Software, San Diego, California USA). We used the t-test for two-group comparisons. Data were represented as the means ± SD. statistical significance difference was accepted in a p-value less than 5%.

Results

Gene expression of NLRP3 inflammasome components and inflammatory cytokines increased in the lung of the COVID-19 group

In the present study, we evaluated the level of NLRP3, ASC, Caspase-1, IL-1β, IL-6 and TNF-α gene expression by Real-time PCR test. The level of NLRP3 gene expression in the lung significantly increased as compared to the Control group (p˂0.0001). There was a significant difference between the COVID-19 group and the Control group in the level of ASC gene expression (p = 0.002). Compared with the Control group, the level of Caspase-1 was statistically increased in the COVID-19 group (p˂0.0001). Similar results were obtained in the Real-time PCR analysis, where the expression of IL-1β and IL-6 genes significantly raised in the COVID-19 group in comparison to the Control group (p = 0.0012 and p˂0.0001 respectively). Following the Coronavirus disease, the level of TNF-α gene expression in the lung meaningfully raised as compared to the Control group (p˂0.0001) (Fig. 1).
Fig. 1

The NLRP3, ASC, Caspase-1, IL-1β, IL-6 and TNF-α genes expression elevated in the lung of COVID-19 group in comparison to the Control group. * p < 0.05 compared to the Control group, ** p < 0.01 compared to the Control group, *** p < 0.001 compared to the Control group and **** p < 0.0001 compared to the Control group (N = 5 per group, 3 replicates)

The NLRP3, ASC, Caspase-1, IL-1β, IL-6 and TNF-α genes expression elevated in the lung of COVID-19 group in comparison to the Control group. * p < 0.05 compared to the Control group, ** p < 0.01 compared to the Control group, *** p < 0.001 compared to the Control group and **** p < 0.0001 compared to the Control group (N = 5 per group, 3 replicates)

The protein level of NLRP3 inflammasome components and inflammatory cytokines increased in the lung of the COVID-19 group

To determine and compare the role of the inflammatory cascade in the lung of COVID-19 and control groups, the level of NLRP3, ASC, Caspase-1, IL-1β, IL-6 and TNF-α proteins level was examined, via ELISA test. There was a significant difference between the COVID-19 group and the Control group in the level of NLRP3 protein level (p < 0.0001). The findings of the present study indicated a significant difference in the level of ASC protein level between the two groups (p = 0.0014). COVID-19 caused a meaningful increase in the level of Caspase-1 protein level as compared to the Control group (p < 0.0001). Similar results were obtained in the ELISA analysis, where the level of IL-1β and IL-6 proteins significantly raised in the COVID-19 group in comparison to the Control group (p < 0.0001 and p < 0.0001 respectively). Following the Coronavirus disease, the level of TNF-α protein in the lung significantly increased as compared to the Control group (p < 0.0001) (Fig. 2).
Fig. 2

The NLRP3, ASC, Caspase-1, IL-1β, IL-6 and TNF-α proteins level elevated in the lung of COVID-19 group in comparison to the Control group. * p < 0.05 compared to the Control group, ** p < 0.01 compared to the Control group, *** p < 0.001 compared to the Control group and **** p < 0.0001 compared to the Control group (N = 5 per group, 3 replicates)

The NLRP3, ASC, Caspase-1, IL-1β, IL-6 and TNF-α proteins level elevated in the lung of COVID-19 group in comparison to the Control group. * p < 0.05 compared to the Control group, ** p < 0.01 compared to the Control group, *** p < 0.001 compared to the Control group and **** p < 0.0001 compared to the Control group (N = 5 per group, 3 replicates)

Histopathological changes were observed in the lung of the COVID-19 group

Histological findings of the present study showed an increase in the number of macrophages in the COVID-19 group (Fig. 3f,h,i), and also a higher density of PMNs infiltration was observed in this group (Fig. 3f,h,i) as compared to the Control group (Fig. 3a,b,c). The results revealed that COVID-19 is characterized by the loss of alveolar structures, and high-grade hemorrhage can be seen between the alveoli (Fig. 3f,g,i). The alteration in the structure of alveoli can cause the loss of type II alveolar epithelial cells, which leads to the disturbance of surfactant production. Injury and inflammation of the arterioles, venules or alveolar septal are the main reasons for hemorrhage in the alveoli. Thickened inter-alveolar septa with a high number of fibroblasts showed fibrotic lung changes (Fig. 3f,h,i) that may lead to blood clots and infections of the lung. Congestion and dilated vessels with lots of blood cells (Fig. 3 g) were observed in the COVID-19 group as compared to the Control group. The total histopathological score was meaningfully higher in the COVID-19 group in comparison with the Control group (p < 0.001) (Fig. 3j) (Fig. 3).
Fig. 3

Photomicrographs showing the pulmonary structure in the Control (a-c) and COVID-19 (d-i) groups. H&E-stained sections showed an increase in the number of macrophages (red arrow) and PMNs infiltration (green arrow) in the COVID-19 group. The results revealed that COVID-19 is characterized by the loss of alveolar structures, and high-grade hemorrhage (red circle) can be seen between the alveoli. Thickened inter-alveolar septa (yellow square) with a high amount of fibroblasts (black-white arrow) showed fibrotic lung changes (light blue rectangular). Congestion and dilated vessels (dark blue ellipsoid) with lots of blood cells were observed in the COVID-19 group. The total histopathological score was significantly higher in the COVID-19 group compared to the Control group (j). (Hematoxylin and eosin stains, a, d ×40, b, e, g ×100, c, f, h, i ×400; Scale bar: All 100 μm), *** p < 0.001 compared to the Control group (N = 5 per group, 5 sections from each corpse)

Photomicrographs showing the pulmonary structure in the Control (a-c) and COVID-19 (d-i) groups. H&E-stained sections showed an increase in the number of macrophages (red arrow) and PMNs infiltration (green arrow) in the COVID-19 group. The results revealed that COVID-19 is characterized by the loss of alveolar structures, and high-grade hemorrhage (red circle) can be seen between the alveoli. Thickened inter-alveolar septa (yellow square) with a high amount of fibroblasts (black-white arrow) showed fibrotic lung changes (light blue rectangular). Congestion and dilated vessels (dark blue ellipsoid) with lots of blood cells were observed in the COVID-19 group. The total histopathological score was significantly higher in the COVID-19 group compared to the Control group (j). (Hematoxylin and eosin stains, a, d ×40, b, e, g ×100, c, f, h, i ×400; Scale bar: All 100 μm), *** p < 0.001 compared to the Control group (N = 5 per group, 5 sections from each corpse)

Discussion

In the present study, we described and compared the NLRP3, ASC, Caspase-1, IL-1β, IL-6 and TNF-α genes expression and their proteins level and histological markers in the lungs of COVID-19 and normal corpses. One of the manifestations of several diseases and infections like COVID-19 is the hyperactivation of the inflammasome complex and also it has been proved that different tissues such as lungs, heart, kidneys and liver to be affected in COVID-19 patients (Mokhtari et al. 2020; Russo et al. 2020; Hassanzadeh et al. 2021). Uncontrolled inflammation can lead to an extreme release of cytokines that is called a cytokine storm. This cytokine storm can lead to alveolar damage and finally reduced gas exchange in different ways like increasing the dead cells and proteins and accumulation of fluid in the lungs which is called edema (Tay et al. 2020). Our results showed that the expression of The NLRP3, ASC, Caspase-1, IL-1β, IL-6 and TNF-α genes significantly increased in the COVID-19 group as compared to the Control group in the lung. Similar to the findings of this study, the findings of clinical studies by Baines et al. (2011, 2010). Baines et al. (2011). In line with the results of the present study, Toldo et al. in 2021 only showed NLRP3 inflammasome components were increased in formalin 10%-fixed lung tissue by IHC in individuals who passed away from fatal COVID-19, but we showed these in both genes expression and proteins level (by Real-time PCR and ELISA, respectively). In addition, these results only indicated the formation of the NLRP3 inflammasome, and it is not enough to show the inflammatory cascade and its effect on lung histophysiology/histopathology. However, we demonstrated the activity of NLRP3 inflammasome that increased the production and secretion of key proinflammatory/inflammatory cytokines (IL-1b, TNF-a, and IL-6) and their effects on histophysiology/histopathology of lung tissue of deceased individuals through COVID-19 (Toldo et al. 2021). The findings of the present study showed that the level of The NLRP3, ASC, Caspase-1, IL-1β, IL-6 and TNF-α proteins in the COVID-19 group meaningfully increased in comparison with the Control group in the lung. Determining the participation of inflammasome-derived products was one of the main goals of the Huang et al. (2020), Lucas et al. (2020), and Wen et al. (2020) studies in 2020. The results of their studies demonstrated the presence of inflammasome-derived products and also cell death and these findings are in agreement with the results of the present study and exhibit the participation of inflammasome in the COVID-19 disease. Rodrigues et al. (2020). The results of Simpson et al. (2014). Pulmonary fibrosis is a condition that appeared when the lung tissue becomes scarred which is observed in the COVID-19 disease and this scar tissue can damage the normal lung that causes breathing becomes increasingly difficult (George et al. 2020; Spagnolo et al. 2020). White blood cells also called leukocytes are the cells of the immune system that are involved in protecting the body against infectious organisms and PMNs such as neutrophils, eosinophils, basophils, and mast cells are a subtype of them. PMNs are placed in the microvasculature of the lung to respond to inflammatory stimuli (Russo et al. 2020). Histological findings of our study presented the increasing number of PMNs, macrophages and also pulmonary fibrosis in the lungs of corpses with the cause of death of COVID-19. Histopathological findings of Tian et al. (2020), Barton et al. (2020), Xu et al. (2020), and Yao et al. (2020) studies in 2020 demonstrated the diffuse alveolar damage, intra-alveolar hemorrhage, intra-alveolar neutrophil infiltration and increased stromal cells in pulmonary tissues which are in line with the results of the present study. Kristine et al. in 2020 in a histological study investigated the postmortem lung findings from a 37-year-old man who died of COVID-19 (Konopka et al. 2020). The results of their study exhibited the presence of paucicellular mucus plugs, goblet cell metaplasia and thickening of subepithelial basement membranes in cartilaginous and non-cartilaginous airways. Furin is a transmembrane protein family which is expressed in several organs, like the lungs and preventing the expression of it could be a possible way to prevent COVID-19 infection (AbdelMassih et al. 2020). The NLRP3 inflammasome can be activated by microbial pathogens, like opportunistic bacteria, atypical bacteria and viruses in the lung (Abdul-Sater et al. 2010; Wang et al. 2014). It seems that, in this study, the mechanism that can be mentioned for lung complication is the attachment of the virus to ACE2 and disturbance of host cells which leads to infect them and raise the inflammatory responses and cell death (Mokhtari et al. 2020).

Conclusion

Infiltration of PMNs and tissue fibrosis and the inflammatory cascade created due to the high activity of the NLRP3 inflammasome complex are directly related to the pathophysiology of the coronavirus-infected lung and its side effects. It is suggested that further studies and targeting of the NLRP3 inflammasome in patients with COVID-19 could be helpful to the achievement of more effective treatment for this disease.
  39 in total

Review 1.  Inflammasomes in health and disease.

Authors:  Till Strowig; Jorge Henao-Mejia; Eran Elinav; Richard Flavell
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

2.  Modulating Pro-inflammatory Cytokines, Tissue Damage Magnitude, and Motor Deficit in Spinal Cord Injury with Subventricular Zone-Derived Extracellular Vesicles.

Authors:  Sahar Ijaz; Ibrahim Mohammed; Morteza Gholaminejhad; Tahmineh Mokhtari; Mohammad Akbari; Gholamreza Hassanzadeh
Journal:  J Mol Neurosci       Date:  2019-11-25       Impact factor: 3.444

Review 3.  Inflammasomes: mechanism of action, role in disease, and therapeutics.

Authors:  Haitao Guo; Justin B Callaway; Jenny P-Y Ting
Journal:  Nat Med       Date:  2015-06-29       Impact factor: 53.440

Review 4.  A multicenter consensus: A role of furin in the endothelial tropism in obese patients with COVID-19 infection.

Authors:  Antoine Fakhry AbdelMassih; Jianping Ye; Aya Kamel; Fady Mishriky; Habiba-Allah Ismail; Heba Amin Ragab; Layla El Qadi; Lauris Malak; Mariam Abdu; Miral El-Husseiny; Mirette Ashraf; Nada Hafez; Nada AlShehry; Nadine El-Husseiny; Nora AbdelRaouf; Noura Shebl; Nouran Hafez; Nourhan Youssef; Peter Afdal; Rafeef Hozaien; Rahma Menshawey; Rana Saeed; Raghda Fouda
Journal:  Obes Med       Date:  2020-07-15

Review 5.  Cytokine Storms: Understanding COVID-19.

Authors:  Nilam Mangalmurti; Christopher A Hunter
Journal:  Immunity       Date:  2020-06-28       Impact factor: 31.745

6.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

7.  The outbreak of COVID-19: An overview.

Authors:  Yi-Chi Wu; Ching-Sung Chen; Yu-Jiun Chan
Journal:  J Chin Med Assoc       Date:  2020-03       Impact factor: 2.743

8.  Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients.

Authors:  Tamara S Rodrigues; Keyla S G de Sá; Adriene Y Ishimoto; Amanda Becerra; Samuel Oliveira; Leticia Almeida; Augusto V Gonçalves; Debora B Perucello; Warrison A Andrade; Ricardo Castro; Flavio P Veras; Juliana E Toller-Kawahisa; Daniele C Nascimento; Mikhael H F de Lima; Camila M S Silva; Diego B Caetite; Ronaldo B Martins; Italo A Castro; Marjorie C Pontelli; Fabio C de Barros; Natália B do Amaral; Marcela C Giannini; Letícia P Bonjorno; Maria Isabel F Lopes; Rodrigo C Santana; Fernando C Vilar; Maria Auxiliadora-Martins; Rodrigo Luppino-Assad; Sergio C L de Almeida; Fabiola R de Oliveira; Sabrina S Batah; Li Siyuan; Maira N Benatti; Thiago M Cunha; José C Alves-Filho; Fernando Q Cunha; Larissa D Cunha; Fabiani G Frantz; Tiana Kohlsdorf; Alexandre T Fabro; Eurico Arruda; Renê D R de Oliveira; Paulo Louzada-Junior; Dario S Zamboni
Journal:  J Exp Med       Date:  2021-03-01       Impact factor: 14.307

Review 9.  Severe Acute Lung Injury Related to COVID-19 Infection: A Review and the Possible Role for Escin.

Authors:  Luca Gallelli; Leiming Zhang; Tian Wang; Fenghua Fu
Journal:  J Clin Pharmacol       Date:  2020-05-22       Impact factor: 2.860

10.  Pathological findings of COVID-19 associated with acute respiratory distress syndrome.

Authors:  Zhe Xu; Lei Shi; Yijin Wang; Jiyuan Zhang; Lei Huang; Chao Zhang; Shuhong Liu; Peng Zhao; Hongxia Liu; Li Zhu; Yanhong Tai; Changqing Bai; Tingting Gao; Jinwen Song; Peng Xia; Jinghui Dong; Jingmin Zhao; Fu-Sheng Wang
Journal:  Lancet Respir Med       Date:  2020-02-18       Impact factor: 30.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.